Investment Management Of Virginia LLC Ligand Pharmaceuticals Inc Transaction History

Investment Management Of Virginia LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$0.01 - $107.56 $6 - $74,646	694 Added 2.48%	28,674 $2.47 Million
Q2 2022 Aug 02, 2022	SELL	$74.52 - $117.06 $690,502 - $1.08 Million	-9,266 Reduced 24.88%	27,980 $2.5 Million
Q1 2022 May 11, 2022	SELL	$94.99 - $151.56 $713,184 - $1.14 Million	-7,508 Reduced 16.78%	37,246 $4.19 Million
Q4 2021 Feb 02, 2022	SELL	$127.69 - $165.85 $50,948 - $66,174	-399 Reduced 0.88%	44,754 $6.91 Million
Q3 2021 Nov 04, 2021	BUY	$102.33 - $144.73 $363,578 - $514,225	3,553 Added 8.54%	45,153 $6.29 Million
Q2 2021 Aug 10, 2021	SELL	$113.03 - $155.64 $274,436 - $377,893	-2,428 Reduced 5.51%	41,600 $5.46 Million
Q1 2021 May 10, 2021	BUY	$99.52 - $215.83 $1.04 Million - $2.25 Million	10,434 Added 31.06%	44,028 $6.71 Million
Q4 2020 Feb 03, 2021	BUY	$80.55 - $106.05 $1.23 Million - $1.61 Million	15,219 Added 82.82%	33,594 $3.34 Million
Q3 2020 Nov 06, 2020	BUY	$89.56 - $126.72 $1.65 Million - $2.33 Million	18,375 New	18,375 $1.75 Million

262

18M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.94B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Investment Management Of Virginia LLC, based on Form 13F filings with the SEC.

Stay updated on Investment Management Of Virginia LLC with notifications on news.